- $0.01m
- $19.43m
- $3.13m
Annual income statement for Trevena, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.031 | 3.07 | 0.567 | -0.418 | 3.13 |
| Cost of Revenue | |||||
| Gross Profit | — | 2.89 | -0.387 | -3.44 | 1.46 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 26.6 | 32.6 | 52.5 | 56 | 38.4 |
| Operating Profit | -26.6 | -29.5 | -51.9 | -56.4 | -35.3 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -24.9 | -29.1 | -51.6 | -53.7 | -40 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -24.9 | -29.4 | -51.6 | -53.7 | -40.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -24.9 | -29.4 | -51.6 | -53.7 | -40.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -24.9 | -29.4 | -51.6 | -53.7 | -40.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -169 | -144 | -197 | -190 | -79.1 |